Bon-Ton Stores Inc. (NASDAQ:BONT) caters to the Services space. It has a net profit margin of -0.50% and weekly performance is -23.32%. On the last day of trading company shares ended up at $2.40. Bon-Ton Stores Inc. (NASDAQ:BONT) distance from 50-day simple moving average (SMA50) is -12.55%.
Bon-Ton Stores Inc. (NASDAQ:BONT) announced the appointment of Nancy A. Walsh to the position of Executive Vice President, Chief Financial Officer of the Company, effective November 9, 2015. Ms. Walsh will have responsibility for Accounting, Treasury, Tax, Credit, Investor Relations, Legal and Internal Audit.
Nutrisystem, Inc. (NASDAQ:NTRI) ended the last trading day at $22.35. Company weekly volatility is calculated as 4.41% and price to cash ratio as 13.82. Nutrisystem, Inc. (NASDAQ:NTRI) showed a weekly performance of -12.52%.
Nutrisystem, Inc. (NASDAQ:NTRI) announced that it is transforming both inside and out. The Company has introduced a new packaging design; new and improved foods with no artificial flavors, colors or sweeteners and easy-to-understand nutritional labels; and an increased fresh-frozen food selection to customers. These significant changes, more than two years in the making, are a nod to the Company’s continued commitment to improve its products and increase customer satisfaction.
On 13 November, Inventure Foods, Inc. (NASDAQ:SNAK) shares moved down -5.08% and was closed at $6.72. SNAK EPS growth in last 5 year was 20.30%. Inventure Foods, Inc. (NASDAQ:SNAK) year to date (YTD) performance is -47.25%.
Inventure Foods, Inc. (NASDAQ:SNAK) had its price objective cut by Wedbush from $13.00 to $12.00 in a report issued on Friday morning, MarketBeat.com reports. They currently have an outperform rating on the stock.
Aeterna Zentaris Inc. (NASDAQ:AEZS) shares moved down -7.80% in last trading session and ended the day at $0.05. AEZS has a return on assets of -56.60%. Aeterna Zentaris Inc. (NASDAQ:AEZS) quarterly performance is -61.58%.
Aeterna Zentaris Inc. (NASDAQ:AEZS) announced that 1,906,451 Series B Common Share Purchase Warrants (the “Series B Warrants”) remained outstanding and that there were approximately 632.7 million Common Shares issued and outstanding at the close of business on November 11, 2015.
Affimed N.V. (NASDAQ:AFMD) caters to the Healthcare space. It has a net profit margin of -69.40% and weekly performance is -6.21%. On the last day of trading company shares ended up at $6.04. Affimed N.V. (NASDAQ:AFMD) distance from 50-day simple moving average (SMA50) is -0.17%.
On 10 November, Affimed N.V. (NASDAQ:AFMD) reported financial results for the quarter ended September 30, 2015. Revenue for the third quarter of 2015 was €1.2 million compared to €1.9 million for the third quarter of 2014. The revenue in the third quarter of 2015 was mainly attributable to revenue achieved under the Amphivena collaboration and revenue generated by our subsidiary AbCheck.
Leave a Reply